Captrust Financial Advisors Bio Techne Corp Transaction History

Captrust Financial Advisors

  • $30 Billion
  • Q1 2024

A detailed history of Captrust Financial Advisors transactions in Bio Techne Corp stock. As of the latest transaction made, Captrust Financial Advisors holds 54,234 shares of TECH stock, worth $3.86 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
54,234
Previous 65,313 16.96%
Holding current value
$3.86 Million
Previous $5.04 Million 24.25%
% of portfolio
0.01%
Previous 0.02%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
SELL
$65.98 - $77.09 $730,992 - $854,080
-11,079 Reduced 16.96%
54,234 $3.82 Million
Q4 2023

Feb 14, 2024
BUY
$52.83 - $78.22 $93,297 - $138,136
1,766 Added 2.78%
65,313 $5.04 Million
Q3 2023

Nov 14, 2023
SELL
$67.52 - $89.42 $43,415 - $57,497
-643 Reduced 1.0%
63,547 $4.33 Million
Q2 2023

Aug 14, 2023
SELL
$73.76 - $85.98 $211,764 - $246,848
-2,871 Reduced 4.28%
64,190 $5.24 Million
Q1 2023

May 15, 2023
SELL
$71.62 - $86.62 $22,417 - $27,112
-313 Reduced 0.46%
67,061 $4.98 Million
Q4 2022

Feb 15, 2023
BUY
$80.67 - $352.29 $4.21 Million - $18.4 Million
52,167 Added 343.05%
67,374 $5.58 Million
Q3 2022

Nov 16, 2022
BUY
$282.54 - $391.85 $685,442 - $950,628
2,426 Added 18.98%
15,207 $4.32 Million
Q2 2022

Aug 23, 2022
SELL
$322.67 - $449.65 $653,084 - $910,091
-2,024 Reduced 13.67%
12,781 $4.43 Million
Q2 2022

Aug 16, 2022
BUY
$322.67 - $449.65 $871,854 - $1.21 Million
2,702 Added 22.33%
14,805 $5.13 Million
Q1 2022

May 16, 2022
BUY
$353.85 - $487.79 $353,142 - $486,814
998 Added 8.99%
12,103 $5.24 Million
Q4 2021

Feb 14, 2022
SELL
$456.15 - $525.06 $83,475 - $96,085
-183 Reduced 1.62%
11,105 $5.75 Million
Q3 2021

Nov 16, 2021
SELL
$444.87 - $538.88 $161,932 - $196,152
-364 Reduced 3.12%
11,288 $5.47 Million
Q2 2021

Aug 16, 2021
SELL
$387.35 - $450.26 $215,366 - $250,344
-556 Reduced 4.55%
11,652 $5.25 Million
Q1 2021

May 17, 2021
BUY
$314.62 - $411.0 $43,417 - $56,718
138 Added 1.14%
12,208 $4.66 Million
Q4 2020

Feb 16, 2021
BUY
$246.9 - $321.87 $42,219 - $55,039
171 Added 1.44%
12,070 $3.83 Million
Q3 2020

Nov 17, 2020
BUY
$232.22 - $282.96 $251,494 - $306,445
1,083 Added 10.01%
11,899 $2.96 Million
Q2 2020

Aug 14, 2020
SELL
$185.43 - $279.56 $65,085 - $98,125
-351 Reduced 3.14%
10,816 $2.88 Million
Q1 2020

May 15, 2020
BUY
$161.17 - $221.51 $27,560 - $37,878
171 Added 1.56%
11,167 $2.07 Million
Q4 2019

Feb 14, 2020
SELL
$189.68 - $222.09 $46,661 - $54,634
-246 Reduced 2.19%
10,996 $2.41 Million
Q3 2019

Nov 14, 2019
BUY
$183.56 - $216.72 $21,476 - $25,356
117 Added 1.05%
11,242 $2.2 Million
Q2 2019

Aug 13, 2019
SELL
$188.72 - $215.43 $943 - $1,077
-5 Reduced 0.04%
11,125 $2.32 Million
Q1 2019

May 15, 2019
BUY
$136.09 - $200.44 $7,621 - $11,224
56 Added 0.51%
11,130 $2.21 Million
Q4 2018

Feb 13, 2019
SELL
$132.75 - $203.8 $3,186 - $4,891
-24 Reduced 0.22%
11,074 $1.6 Million
Q3 2018

Nov 15, 2018
SELL
$147.44 - $204.11 $10,320 - $14,287
-70 Reduced 0.63%
11,098 $2.27 Million
Q2 2018

Aug 13, 2018
SELL
$144.9 - $165.58 $78,535 - $89,744
-542 Reduced 4.63%
11,168 $1.65 Million
Q1 2018

May 15, 2018
BUY
$131.46 - $151.04 $11,305 - $12,989
86 Added 0.74%
11,710 $1.7 Million
Q4 2017

Feb 14, 2018
BUY
$121.17 - $134.75 $75,610 - $84,084
624 Added 5.67%
11,624 $1.51 Million
Q3 2017

Feb 16, 2018
BUY
$113.59 - $123.78 $1.25 Million - $1.36 Million
11,000
11,000 $1.51 Million

Others Institutions Holding TECH

# of Institutions
581
Shares Held
154M
Call Options Held
180K
Put Options Held
189K
View Full List

About BIO-TECHNE Corp

TECH Quotes by TradingView
  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.79B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Captrust Financial Advisors Portfolio

Follow Captrust Financial Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Captrust Financial Advisors with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email